GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+3.43%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.3B
AUM Growth
–
Cap. Flow
+$4.29B
Cap. Flow
% of AUM
99.89%
Top 10 Holdings %
Top 10 Hldgs %
20.38%
Holding
495
New
494
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price
TROW
|
+$119M |
| 2 |
Tractor Supply
TSCO
|
+$92M |
| 3 |
Amazon
AMZN
|
+$87.9M |
| 4 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$86.5M |
| 5 |
SBA Communications
SBAC
|
+$85.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.85% |
| 2 | Energy | 14.65% |
| 3 | Financials | 14.18% |
| 4 | Industrials | 13.85% |
| 5 | Technology | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Yum! Brands
YUM
$40B
| $1.16M | 0.03% |
+23,232
| New | +$1.15M |
2013 Q2
0 quarters
|
|
202
iShares MSCI EAFE ETF
EFA
$76.3B
| $1.15M | 0.03% |
+19,977
| New | +$1.21M |
2013 Q2
0 quarters
|
|
203
Norfolk Southern
NSC
$72.7B
| $1.14M | 0.03% |
+15,659
| New | +$1.2M |
2013 Q2
0 quarters
|
|
204
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $1.1M | 0.03% |
+28,428
| New | +$1.19M |
2013 Q2
0 quarters
|
|
|
CTU.CL
205
DELISTED
Qwest Corporation
CTU.CL
| $1.1M | 0.03% |
+42,500
| New | +$1.13M |
2013 Q2
0 quarters
|
|
|
CMCSK
206
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $1.07M | 0.03% |
+27,042
| New | +$1.07M |
2013 Q2
0 quarters
|
|
207
FedEx
FDX
$68.9B
| $1.06M | 0.02% |
+10,755
| New | +$1.04M |
2013 Q2
0 quarters
|
|
208
TechnipFMC
FTI
$27.3B
| $1.06M | 0.02% |
+25,549
| New | +$1.04M |
2013 Q2
0 quarters
|
|
209
iShares Core S&P Small-Cap ETF
IJR
$102B
| $1.05M | 0.02% |
+23,370
| New | +$1.03M |
2013 Q2
0 quarters
|
|
210
CVS Health
CVS
$116B
| $1.04M | 0.02% |
+18,213
| New | +$1.06M |
2013 Q2
0 quarters
|
|
211
State Street SPDR S&P 500 ETF Trust
SPY
$813B
| $1.04M | 0.02% |
+6,477
| New | +$1.04M |
2013 Q2
0 quarters
|
|
|
CEB
212
DELISTED
CEB Inc.
CEB
| $1.01M | 0.02% |
+16,003
| New | +$942K |
2013 Q2
0 quarters
|
|
213
Eli Lilly
LLY
$1.08T
| $1.01M | 0.02% |
+20,580
| New | +$1.12M |
2013 Q2
0 quarters
|
|
214
Axos Financial
AX
$4.91B
| $1.01M | 0.02% |
+88,120
| New | +$916K |
2013 Q2
0 quarters
|
|
|
ARG
215
DELISTED
Airgas Inc
ARG
| $1.01M | 0.02% |
+10,570
| New | +$1.04M |
2013 Q2
0 quarters
|
|
216
iShares Russell 1000 ETF
IWB
$49B
| $1.01M | 0.02% |
+11,186
| New | +$1M |
2013 Q2
0 quarters
|
|
217
DELISTED
EMC CORPORATION
EMC
| $1M | 0.02% |
+42,460
| New | +$1M |
2013 Q2
0 quarters
|
|
218
Mondelez International
MDLZ
$79.9B
| $1M | 0.02% |
+35,089
| New | +$1.07M |
2013 Q2
0 quarters
|
|
219
Edwards Lifesciences
EW
$49.8B
| $989K | 0.02% |
+88,266
| New | +$1.04M |
2013 Q2
0 quarters
|
|
220
Netflix
NFLX
$294B
| $971K | 0.02% |
+322,000
| New | +$958K |
2013 Q2
0 quarters
|
|
221
AbbVie
ABBV
$501B
| $966K | 0.02% |
+23,364
| New | +$1.02M |
2013 Q2
0 quarters
|
|
222
3M
MMM
$84.8B
| $962K | 0.02% |
+10,525
| New | +$956K |
2013 Q2
0 quarters
|
|
223
Blackrock
BLK
$166B
| $945K | 0.02% |
+3,678
| New | +$985K |
2013 Q2
0 quarters
|
|
224
Cisco
CSCO
$448B
| $910K | 0.02% |
+37,415
| New | +$842K |
2013 Q2
0 quarters
|
|
225
BioMarin Pharmaceuticals
BMRN
$10.7B
| $902K | 0.02% |
+16,180
| New | +$1.01M |
2013 Q2
0 quarters
|
|
Similar funds
CAM
VKH
DL
RBC
TCM
HCM
AL
AT
Geneva Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Geneva Advisors, which disclosed 495 positions worth $4.3B. Its ten largest holdings account for 20% of the portfolio.
Its largest position is T. Rowe Price: 1,589,950 shares worth $116M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, followed by Energy and Financials.
- Geneva Advisors's largest Q2 2013 buy was T. Rowe Price: 1,589,950 shares worth $116M.
- Geneva Advisors's ten largest holdings make up 20% of its $4.3B portfolio in Q2 2013.
- Geneva Advisors disclosed 495 positions in Q2 2013, its first 13F filing on record.
Based on Geneva Advisors's 13F filing for Q2 2013, filed 6 Aug 2013.